PhosPrint at 2024 World Congress of the SIU in Delhi, India

Thrilled to announce PhosPrint’s participation in the 2024 World Congress of the Société Internationale d'Urologie (SIU) in Delhi, India, where our co-founder and Clinical Director, Apostolos Klinakis, presented the exciting and promising results from our animal studies.

Our data demonstrate that our invivo laser bioprinted neobladder method is safe and eliminates side effects, offering an innovative solution to improve patients' quality of life.

Exhibitor Data Sheet

.fairmate_js_notification_overlay { z-index: 9000; position: fixed; top: 0; bottom: 0; left: 0; right: 0; background-color: rgb(204, 204, 204); background-color: rgba(204, 204, 204, 0.7); } .fairmate_js_notification_popup_dlg { background-color: #fff !important; margin-left: auto; margin-right: auto; width: 570px; margin-top: 10%; } .fairmate_js_notification_popup_header { display: flex; justify-content: center; padding: 10px; } .fairmate_js_notification_popup_content { padding: 10px 60px 30px; } .fairmate_js_notification_popup_footer { display: flex; justify-content: center; padding-bottom: 30px; }

This page requires JavaScript

To use the full function of this web site, JavaScript needs to be enabled in your browser.

This is how you enable JavaScript in your browser settings:
Read instruction